Qiuyu Mo
Overview
Explore the profile of Qiuyu Mo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang K, Mo Q, Liao C, Feng S, Liu G, Jiang D, et al.
Clin Exp Med
. 2024 May;
24(1):107.
PMID: 38776019
Predicting the likelihood vascular events in patients with BCR/ABL1-negative myeloproliferative neoplasms (MPN) is essential for the treatment of the disease. However, effective assessment methods are lacking. Thrombin-antithrombin complex (TAT), plasmin-α-...
2.
Li W, Yuan P, Liu W, Xiao L, Xu C, Mo Q, et al.
Front Immunol
. 2022 Aug;
13:843369.
PMID: 35958555
Background: Multiple myeloma (MM) remains an incurable malignant tumor of plasma cells. Increasing evidence has reported that hypoxia and immune status contribute to the progression of MM. In this research,...
3.
Jiang D, Mo Q, Sun X, Wang X, Dong M, Zhang G, et al.
Cancer Sci
. 2021 Jul;
112(9):3585-3597.
PMID: 34252986
Diffuse large B cell lymphoma (DLBCL) heterogeneity promotes recurrence and anti-CD20-based therapeutic resistance. Previous studies have shown that downregulation of MS4A1/CD20 expression after chemoimmunotherapy with rituximab leads to rituximab resistance....
4.
Zhao Q, Jiang D, Sun X, Mo Q, Chen S, Chen W, et al.
J Nanobiotechnology
. 2021 Jun;
19(1):179.
PMID: 34120620
Background: Non-Hodgkin's lymphoma (NHL) is a malignant disease of lymphoid tissue. At present, chemotherapy is still the main method for the treatment of NHL. R-CHOP can significantly improve the survival...
5.
Jiang D, He Y, Mo Q, Liu E, Li X, Huang L, et al.
J Transl Med
. 2021 May;
19(1):211.
PMID: 34001134
Background: Prickle planar cell polarity protein 1 (PRICKLE1), a core component of the non-canonical Wnt/planar cell polarity (PCP) pathway, was recently reported to be upregulated and correlated with poor prognosis...